3rd Nov 2008 07:00
PuriCore plc
("PuriCore" or "the Company")
Notification of PDMR Interest - Option Award
MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 3 November 2008 - PuriCore (LSE: PURI), the life sciences company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, announces that on 1 November 2008 Darren Weiss, VP Finance, was granted options (the "Options") over 100,000 Ordinary Shares of 1p each in the Company ("Ordinary Shares") under the PuriCore plc Executive Omnibus Incentive Plan. The Options are to vest in amounts of one-third of the total grant per year over three years, exercisable from the date of vesting until the fifth anniversary of the date of grant at an exercise price of 10.25 pence per share.
Following this grant Darren Weiss holds options over 485,000 Ordinary Shares.
Enquiries:
|
Ben Brewerton |
Greg Bosch, CEO |
|
Susan Quigley |
Darren Weiss, VP Finance |
|
Financial Dynamics |
PuriCore |
|
+44 (0) 20 7831 3113 |
+1 484 321 2700 |
About PuriCore
PuriCore plc (LSE: PURI) is a life sciences company focused on developing and commercialising proprietary green solutions that safely, effectively, and naturally kill infectious pathogens. PuriCore targets markets that depend upon controlling contamination, including food safety in retail and foodservice, medical device disinfection, and wound therapy. The Company's patented, proprietary technology mimics the human body's production of the natural antimicrobial hypochlorous acid, which is highly effective in killing bacteria, viruses, and fungal spores, simply from water, common salt, and electricity. Hypochlorous acid is proven to be safe, environmentally friendly, and fast acting against a broad range of infectious pathogens, including major public health threats of M. tuberculosis, MRSA, E.coli, Norovirus, H5N1 Avian Influenza, HIV, Salmonella, Polio Virus, Helicobater pylori, and Legionella. PuriCore is headquartered in Malvern, Pennsylvania, with offices in Stafford, UK.
To receive additional information on PuriCore, please visit our website at www.puricore.com, which does not form part of this press release.
To subscribe to our investor news alerts, visit http://investor.puricore.com.
Related Shares:
RLM.L